"Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis". Bone. 41 ... "Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study ... This type of drug has a high affinity for hydroxyapatite and stays in bone tissue for a long period of time, with alendronate, ... Owing to prolonged embedding of bisphosphonate drugs in the bone tissues, the risk for MRONJ is elevated even after stopping ...

The bisphosphonate drug alendronate may decrease the risk of a fracture, in women that have both bone loss and a previous ... The annual rates of bone mineral density loss are highest starting one year before the final menstrual period and continuing ... MHT is also effective for preventing bone loss and osteoporotic fracture, but it is generally recommended only for women at ... For example in 2018 in the UK women aged 45-54 report more work-related stress than men or women of any other age group. Hot ...